Aurobindo Pharma Q2 PAT may dip 23% YoY to Rs. 601.9 cr: ICICI Direct

ICICI Direct has come out with its second quarter (July-September’ 18) earnings estimates for the Healthcare sector. The brokerage house expects Aurobindo Pharma to report net profit at Rs. 601.9 crore down 23% year-on-year (up 32.1% quarter-on-quarter).

Net Sales are expected to increase by 4.6 percent Y-o-Y (up 9.1 percent Q-o-Q) to Rs. 4,638.9 crore, according to ICICI Direct.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 13.7 percent Y-o-Y (up 35.6 percent Q-o-Q) to Rs. 964.3 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.